Concepedia

Jennifer K. Litton

JK

Statistics

Publications

162

Citations

20.6K

H-Index

64

Active since

2007

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Baylor College of Medicine

Brigham and Women's Hospital

UCSF Helen Diller Family Comprehensive Cancer Center

Dana-Farber Brigham Cancer Center

Jennifer K. Litton is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and breast oncology.

Publications per year

2007–2025

162

Publications

162

Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation

Jennifer K. Litton, Hope S. Rugo, Johannes Ettl et al. · New England Journal of Medicine · 2018 · 2.2K citations · Full text

Medicine, Oncology, Pharmacology +14

PD-L1 Expression in Triple-Negative Breast Cancer

Elizabeth A. Mittendorf, Anne V. Philips, Funda Meric‐Bernstam et al. · Cancer Immunology Research · 2014 · 1.4K citations · Full text

Medicine, Molecular Biology, Oncology +17

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Mary B. Daly, Tuya Pal, Michael P. Berry et al. · Journal of the National Comprehensive Cancer Network · 2021 · 1.1K citations · Full text

Medicine, Genetics, Oncology +17

PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression

Shiping Jiao, Weiya Xia, Hirohito Yamaguchi et al. · Clinical Cancer Research · 2017 · 975 citations

Medicine, Immunology, Oncology +17

Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1

Jong‐Ho Cha, Wenhao Yang, Weiya Xia et al. · Molecular Cell · 2018 · 758 citations

Medicine, Immunology, Oncology +14

1–5 of 162